Lung Carcinoma

Oncology
2
Pipeline Programs
3
Companies
4
Clinical Trials
2 recruiting
1
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
1
Early DiscoveryClinical DevelopmentMarket

On Market (1)

Approved therapies currently available

U
TYRVAYAApproved
varenicline
Unknown Company
nasal2021

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Alliance Pharmaceuticals
2 programs
1
VareniclinePhase 31 trial
cytology specimen collection procedureN/A1 trial
Active Trials
NCT00899782Completed500Est. Feb 2022
NCT02856581Terminated23Est. Apr 2022
Knight Therapeutics
Knight TherapeuticsQC - Montréal
1 program
Best PracticeN/A1 trial
Active Trials
NCT05407168Recruiting300Est. Dec 2027
Varian Medical Systems
1 program
Computed TomographyN/A1 trial
Active Trials
NCT05802186RecruitingEst. Mar 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Alliance PharmaceuticalsVarenicline
Varian Medical SystemsComputed Tomography
Knight TherapeuticsBest Practice
Alliance Pharmaceuticalscytology specimen collection procedure

Clinical Trials (4)

Total enrollment: 823 patients across 4 trials

Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes

Start: Sep 2017Est. completion: Apr 202223 patients
Phase 3Terminated

Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study

Start: Nov 2023Est. completion: Mar 2026
N/ARecruiting

Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool

Start: Oct 2022Est. completion: Dec 2027300 patients
N/ARecruiting
NCT00899782Alliance Pharmaceuticalscytology specimen collection procedure

Collection and Storage of Blood and Tissue Samples From Patients Who Are Undergoing Surgery For Lung Cancer

Start: Jul 2004Est. completion: Feb 2022500 patients
N/ACompleted

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
2 actively recruiting trials targeting 823 patients
3 companies competing in this space